Gilbert M Wilcox1, Anthony R Mattia. 1. Department of Gastroenterology, Maine Medical Center, Portland, ME, USA. gwilcox1@maine.rr.com
Abstract
GOALS: The aim of this study was to determine whether proton pump inhibitors other than lansoprazole might be associated with microscopic colitis. BACKGROUND: Lansoprazole exposure has been associated with diarrhea and microscopic colitis, but this relationship has not been described with other proton pump inhibitors. STUDY: Cases of microscopic colitis from a consultative gastroenterology practice were collected and reviewed for proton pump inhibitor exposure. Standard clinical, endoscopic, and biopsy findings were analyzed. RESULTS: A case series of 4 patients is described in which subjects developed classic symptoms of lymphocytic-collagenous colitis with typical mucosal histopathology during treatment with omeprazole/esomeprazole. Symptoms promptly stopped and mucosal biopsies returned to normal with drug withdrawal. Disease quickly recurred in 2 patients who were reexposed to the drugs, one with biopsy documented recurrent collagenous colitis. CONCLUSIONS: Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure. These results have epidemiologic, diagnostic, and therapeutic ramifications, which are discussed.
GOALS: The aim of this study was to determine whether proton pump inhibitors other than lansoprazole might be associated with microscopic colitis. BACKGROUND:Lansoprazole exposure has been associated with diarrhea and microscopic colitis, but this relationship has not been described with other proton pump inhibitors. STUDY: Cases of microscopic colitis from a consultative gastroenterology practice were collected and reviewed for proton pump inhibitor exposure. Standard clinical, endoscopic, and biopsy findings were analyzed. RESULTS: A case series of 4 patients is described in which subjects developed classic symptoms of lymphocytic-collagenous colitis with typical mucosal histopathology during treatment with omeprazole/esomeprazole. Symptoms promptly stopped and mucosal biopsies returned to normal with drug withdrawal. Disease quickly recurred in 2 patients who were reexposed to the drugs, one with biopsy documented recurrent collagenous colitis. CONCLUSIONS: Some cases of microscopic colitis seem to be associated with omeprazole/esomaprazole exposure. These results have epidemiologic, diagnostic, and therapeutic ramifications, which are discussed.
Authors: Monina F Pascua; Prashant Kedia; Mark G Weiner; John Holmes; Jonas Ellenberg; James D Lewis Journal: Clin Med Insights Gastroenterol Date: 2010-05-18
Authors: Gwen M C Masclee; Preciosa M Coloma; Ernst J Kuipers; Miriam C J M Sturkenboom Journal: Am J Gastroenterol Date: 2015-04-28 Impact factor: 10.864
Authors: Yeon Hwa Yu; Dong Soo Han; Eun Young Choi; Hye Sun Park; Jae Yoon Jeong; Chang Soo Eun; Young Ha Oh; Ju Yeon Pyo Journal: Dig Dis Sci Date: 2012-08-02 Impact factor: 3.199
Authors: Kristin E Burke; Ashwin N Ananthakrishnan; Paul Lochhead; Po-Hong Liu; Ola Olen; Jonas F Ludvigsson; James M Richter; Shelley S Tworoger; Andrew T Chan; Hamed Khalili Journal: Gastroenterology Date: 2018-08-23 Impact factor: 22.682